Luis Javier Martinez Morales | Genetics | Best Researcher Award

Prof Dr. Luis Javier Martinez Morales | Genetics| Best Researcher Award

Prof Dr.Luis Javier Martinez Morales,Benemerita Universidad Autonoma de Puebla,Mexico

Prof. Dr. Luis Javier Martínez Morales is a distinguished academic and researcher at the Benemérita Universidad Autónoma de Puebla (BUAP) in Mexico. With extensive experience in his field, he is recognized for his contributions to advancing scientific knowledge and education. Dr. Martínez Morales has published numerous research papers and has been actively involved in various academic initiatives that promote innovation and development within his area of expertise. His work continues to inspire students and professionals alike, enhancing the academic reputation of BUAP.

Profile

Education

Dr. Bhattacharyya holds a Ph.D. in Biophysics, along with the prestigious MAMS qualification. Her academic background is rooted in a deep understanding of cellular biology and the physiological mechanisms that underlie stem cell and cancer research. Through her advanced education, she has cultivated a deep expertise in biophysics, with a focus on the practical application of scientific knowledge to medical challenges.

Professional Experience

Currently serving as a professor and the Head of the Department of Biophysics at PGIMER, Chandigarh, Dr. Bhattacharyya has built a distinguished career in academia and research. Her role involves overseeing significant research projects, mentoring students, and leading pioneering studies in stem cell therapies and cancer biology. Over the years, she has cultivated extensive experience in research leadership, having successfully led and collaborated on multiple national and international research projects funded by institutions like ICMR, CSIR, and UGC.

Research Interest

 Dr. Bhattacharyya’s primary research interests lie in regenerative medicine, cancer biology, and tissue engineering. She focuses on utilizing human mesenchymal stem cells from bone marrow, dental pulp, and adipose tissues for regenerative applications. Her laboratory has pioneered studies involving ex vivo models for bone regeneration, cell-free therapies using biocompatible scaffolds, and personalized approaches to cancer therapy via patient-derived organoids. She is also actively engaged in cancer stem cell research, with an emphasis on therapy resistance, metastasis, and tumor microenvironment interactions.

Research Skills

Dr. Bhattacharyya is highly skilled in stem cell culture, 3D spheroid technology, patient-derived organoid generation, and tissue engineering techniques. Her expertise extends to developing and applying biomaterials, scaffolds, and acellular products such as exosomes and mitochondria for regenerative purposes. In cancer biology, she has excelled in studying cellular physiology, therapy resistance, epithelial-to-mesenchymal transition, and cancer stem cell behavior. Her skills also encompass project management, grant acquisition, and mentoring emerging researchers in her field.

Award and Recognition

Dr. Bhattacharyya has received numerous accolades for her outstanding contributions to biomedical research. Her work has been recognized by leading research bodies, including ICMR, CSIR, and UGC, through extramural grants for her innovative projects in stem cell therapy, cancer research, and tissue engineering. Her leadership in developing cutting-edge models for personalized cancer treatment and regenerative medicine has established her as a respected figure in the scientific community. She continues to garner recognition for her efforts to advance biomedical research and improve therapeutic outcomes through novel approaches.

Conclusion

Dr. Shalmoli Bhattacharyya’s expertise in stem cell research, cancer biology, and regenerative medicine, backed by her leadership as the Head of Biophysics at PGIMER, makes her a strong contender for the “Best Researcher Award.” Her impressive track record in pioneering novel biomedical approaches and securing significant funding showcases her excellence in the field. With further enhancements in international collaboration and interdisciplinary research, she can elevate her already impactful work to even greater heights, solidifying her reputation as a leading researcher.

Publication Top Notes

“Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)”

Year: 2021

Journal: Autophagy

“Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis”

Year: 2015

Journal: BioResearch Open Access

“Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer”

Year: 2014

Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease

“Secretome cues modulate the neurogenic potential of bone marrow and dental stem cells”

Year: 2017

Journal: Molecular Neurobiology

“JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells”

Year: 2016

Journal: Biochimica et Biophysica Acta (BBA) – General Subjects

“The hepatoprotective potential of Spirulina and vitamin C supplementation in cisplatin toxicity”

Year: 2012

Journal: Food & Function

“Autophagy as a potential therapeutic target during epithelial to mesenchymal transition in renal cell carcinoma: An in vitro study”

Year: 2017

Journal: Biomedicine & Pharmacotherapy

“Molecular spectrum of secretome regulates the relative hepatogenic potential of mesenchymal stem cells from bone marrow and dental tissue”

Year: 2017

Journal: Scientific Reports

“Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent”

Year: 2014

Journal: The Journal of Urology

“Secretome proteins regulate comparative osteogenic and adipogenic potential in bone marrow and dental stem cells”

Year: 2018

Journal: Biochimie

Shalmoli Bhattacharyya | Molecular Biology | Best Researcher Award

Shalmoli Bhattacharyya | Molecular Biology | Best Researcher Award

Professor & Head of PGIMER, India.

Dr. Shalmoli Bhattacharyya is a distinguished professor and the Head of the Department of Biophysics at PGIMER, Chandigarh, India. With a Ph.D. and over a decade of experience in the fields of stem cell research, regenerative medicine, and cancer biology, she has significantly contributed to the advancement of biomedical sciences. Her work is focused on developing cutting-edge therapies using stem cells, biomaterials, and patient-derived organoids, with a strong emphasis on personalized medicine. Dr. Bhattacharyya’s leadership in translational research has established her as a leading figu

Profile

Education

Dr. Bhattacharyya holds a Ph.D. in Biophysics, along with the prestigious MAMS qualification. Her academic background is rooted in a deep understanding of cellular biology and the physiological mechanisms that underlie stem cell and cancer research. Through her advanced education, she has cultivated a deep expertise in biophysics, with a focus on the practical application of scientific knowledge to medical challenges.

Professional Experience

Currently serving as a professor and the Head of the Department of Biophysics at PGIMER, Chandigarh, Dr. Bhattacharyya has built a distinguished career in academia and research. Her role involves overseeing significant research projects, mentoring students, and leading pioneering studies in stem cell therapies and cancer biology. Over the years, she has cultivated extensive experience in research leadership, having successfully led and collaborated on multiple national and international research projects funded by institutions like ICMR, CSIR, and UGC.

Research Interest

 Dr. Bhattacharyya’s primary research interests lie in regenerative medicine, cancer biology, and tissue engineering. She focuses on utilizing human mesenchymal stem cells from bone marrow, dental pulp, and adipose tissues for regenerative applications. Her laboratory has pioneered studies involving ex vivo models for bone regeneration, cell-free therapies using biocompatible scaffolds, and personalized approaches to cancer therapy via patient-derived organoids. She is also actively engaged in cancer stem cell research, with an emphasis on therapy resistance, metastasis, and tumor microenvironment interactions.

Research Skills

Dr. Bhattacharyya is highly skilled in stem cell culture, 3D spheroid technology, patient-derived organoid generation, and tissue engineering techniques. Her expertise extends to developing and applying biomaterials, scaffolds, and acellular products such as exosomes and mitochondria for regenerative purposes. In cancer biology, she has excelled in studying cellular physiology, therapy resistance, epithelial-to-mesenchymal transition, and cancer stem cell behavior. Her skills also encompass project management, grant acquisition, and mentoring emerging researchers in her field.

Award and Recognition

Dr. Bhattacharyya has received numerous accolades for her outstanding contributions to biomedical research. Her work has been recognized by leading research bodies, including ICMR, CSIR, and UGC, through extramural grants for her innovative projects in stem cell therapy, cancer research, and tissue engineering. Her leadership in developing cutting-edge models for personalized cancer treatment and regenerative medicine has established her as a respected figure in the scientific community. She continues to garner recognition for her efforts to advance biomedical research and improve therapeutic outcomes through novel approaches.

Conclusion

Dr. Shalmoli Bhattacharyya’s expertise in stem cell research, cancer biology, and regenerative medicine, backed by her leadership as the Head of Biophysics at PGIMER, makes her a strong contender for the “Best Researcher Award.” Her impressive track record in pioneering novel biomedical approaches and securing significant funding showcases her excellence in the field. With further enhancements in international collaboration and interdisciplinary research, she can elevate her already impactful work to even greater heights, solidifying her reputation as a leading researcher.

Publication Top Notes

“Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)”

Year: 2021

Journal: Autophagy

“Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis”

Year: 2015

Journal: BioResearch Open Access

“Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer”

Year: 2014

Journal: Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease

“Secretome cues modulate the neurogenic potential of bone marrow and dental stem cells”

Year: 2017

Journal: Molecular Neurobiology

“JAK-mediated autophagy regulates stemness and cell survival in cisplatin resistant bladder cancer cells”

Year: 2016

Journal: Biochimica et Biophysica Acta (BBA) – General Subjects

“The hepatoprotective potential of Spirulina and vitamin C supplementation in cisplatin toxicity”

Year: 2012

Journal: Food & Function

“Autophagy as a potential therapeutic target during epithelial to mesenchymal transition in renal cell carcinoma: An in vitro study”

Year: 2017

Journal: Biomedicine & Pharmacotherapy

“Molecular spectrum of secretome regulates the relative hepatogenic potential of mesenchymal stem cells from bone marrow and dental tissue”

Year: 2017

Journal: Scientific Reports

“Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent”

Year: 2014

Journal: The Journal of Urology

“Secretome proteins regulate comparative osteogenic and adipogenic potential in bone marrow and dental stem cells”

Year: 2018

Journal: Biochimie

Rida Khalil | Nanomedicine | Best Researcher Award

Ms. Rida Khalil | Nanomedicine | Best Researcher Award

Mphil Scoholar of Quaid-e-Azam University Islamabad, Pakistan.

Ms. Rida Khalil is a dedicated pharmacist and research scholar with a strong academic background and practical experience in pharmaceutics. She is pursuing an M.Phil in Pharmaceutics at Quaid-e-Azam University, Islamabad, with a research focus on enhancing methylphenidate bioavailability through innovative drug delivery systems. Her Pharm-D degree from the University of Veterinary and Animal Sciences, Lahore, provided a solid foundation in pharmacology and pharmaceutical technology. Rida’s hands-on experience includes an internship at Children Hospital, Lahore, where she gained valuable insights into clinical and emergency pharmacy. She has actively participated in professional events, including organizing World Pharmacist Day and presenting research at international conferences. Recognized with awards such as the Best Presenter Debater Award and the M.Phil Fellowship, she demonstrates strong communication skills and academic excellence. Rida’s commitment to advancing pharmaceutical science and improving patient care makes her a promising candidate for further research accolades.

Profile

Education

Ms. Rida Khalil’s educational journey reflects a strong commitment to pharmaceutical science and research. She is currently pursuing an M.Phil in Pharmaceutics at Quaid-e-Azam University, Islamabad, where she is working on a groundbreaking research project titled “Intranasal Transfersomal Based In Situ Gel for Augmenting Methylphenidate Bioavailability and Brain Delivery,” achieving a notable GPA of 3.7/4. Her academic foundation was laid at the University of Veterinary and Animal Sciences, Lahore, where she earned her Pharm-D degree with a CGPA of 3.69/4. During her undergraduate studies, she covered a wide array of subjects including pharmacology, pharmaceutical technology, and clinical pharmacy. Prior to her higher education, Rida completed her pre-medical studies at Punjab College for Girls, Jhelum, and her secondary education at FG Girls Higher Secondary School, Jhelum, with outstanding academic performance. Her educational background underscores her dedication to advancing pharmaceutical sciences and drug development.

Professional Experience

Ms. Rida Khalil has demonstrated a strong foundation in pharmaceutical practice and research through her diverse professional experiences. Her internship at City Children Hospital, Lahore, in 2019 provided her with hands-on experience in various pharmacy settings, including total parenteral nutrition, retail and emergency pharmacy, and clinical pharmacy. This role allowed her to apply her academic knowledge in real-world scenarios, enhancing her practical skills and patient care capabilities. Additionally, Rida’s involvement in organizing and speaking at events such as the World Pharmacist Day and presenting her pilot project on iron deficiency at the 20th International Pharmacy Conference underscores her commitment to advancing pharmaceutical sciences and public health. Her active engagement in mental health awareness programs and innovative projects, like the mucoadhesive buccal patch of insulin, further reflects her dedication to impactful research and community service.

Research Interest

Ms. Rida Khalil’s research interests lie at the intersection of pharmacology and drug development, with a particular focus on innovative drug delivery systems. Her current M.Phil research investigates the formulation of an intranasal transfersomal-based in situ gel aimed at enhancing the bioavailability and brain delivery of methylphenidate. This project reflects her commitment to advancing therapeutic methods and improving patient outcomes through novel delivery mechanisms. Additionally, Rida has explored areas such as the development of mucoadhesive buccal patches for insulin delivery and the effects of iron deficiency on cognitive function. Her interest in these topics underscores a broader aim to address challenges in pharmaceutical technology and patient care. Rida’s research is driven by a passion for creating impactful healthcare solutions and contributing to the field’s advancement through detailed and innovative approaches.

Research Skills

Ms. Rida Khalil possesses a range of research skills that reflect her expertise in pharmacology and drug development. Her M.Phil research on “Intranasal Transfersomal Based In Situ Gel for Augmenting Methylphenidate Bioavailability and Brain Delivery” showcases her proficiency in advanced drug delivery systems, combining both in vitro and in vivo evaluations. Her Pharm-D background provides a strong foundation in physical pharmacy, pharmaceutical technology, and pharmacology, equipping her with essential skills for comprehensive drug research. Rida’s practical experience, including her internship at Children Hospital, Lahore, has enhanced her understanding of clinical pharmacy and emergency care. She is adept in utilizing software tools like Origin, Sigma Plot, and Design Expert for data analysis and project design. Additionally, her experience in organizing and presenting at conferences underscores her ability to communicate complex research findings effectively. These skills collectively underscore Rida’s capability to contribute significantly to pharmaceutical research.

Award and Recognition

Ms. Rida Khalil has earned notable recognition for her contributions to the field of pharmaceutics and drug development. Her academic excellence is demonstrated by her impressive performance in her M.Phil program at Quaid-e-Azam University, Islamabad, where she focused on innovative drug delivery systems. Rida’s research on enhancing methylphenidate bioavailability through novel in situ gels underscores her commitment to advancing pharmaceutical science. She has been awarded the Best Presenter Debater Award in 2019 for her exceptional presentation skills and the M.Phil Fellowship in 2024, recognizing her potential and dedication to her research. Her work has been further acknowledged by the Higher Education Commission (HEC) with a merit scholarship. Rida’s active role in organizing and presenting at professional events, such as the World Pharmacist Day and international conferences, highlights her commitment to both research excellence and professional development.

Conclusion

Rida Khalil has shown commendable dedication to pharmaceutical research through her innovative projects, solid educational background, and active professional engagement. Her practical experience and accolades further highlight her potential as a leading researcher. To enhance her candidacy for the Research for Best Researcher Award, focusing on increasing her publication record, expanding her research scope, and engaging in international collaborations would be beneficial. Her passion and commitment to advancing pharmaceutical science make her a strong contender for the award, provided she continues to build on these areas.

Publication Top Notes

  1. Intranasal transfersomal based in situ gel for augmenting methylphenidate bioavailability and brain delivery: In vitro and in vivo evaluation
  • Journal: Journal of Drug Delivery Science and Technology
  • Year: 2024
  • DOI: 10.1016/j.jddst.2024.106125
  • Authors: Rida Khalil, Rashna Mirza, Kifayat Ullah Shah, Atif Ullah Khan, Irfan Ismail, Shefaat Ullah Shah, Wasi Ullah, Sakina Niyazi, Abdullah R. Alanzi, Stephane Gibaud et al.

 

GHADEER SUAIFAN | Pharmaceutical Sciences | Best Researcher Award

Prof GHADEER SUAIFAN | Pharmaceutical Sciences | Best Researcher Award

Research Scholar, The University of Jordan, Jordan

Ghadeer A. Suaifan was born in December 1973 and is a Jordanian national. She is fluent in both Arabic and English. Ghadeer holds a PhD and an MPhil in Medicinal Chemistry and Instrumental Analysis from the University of Bath, UK, and a BSc (Honours) in Pharmacy from Petra University, Jordan. She currently serves as a Professor of Medicinal Chemistry and Pharmaceutical Instrumental Analysis at the Faculty of Pharmacy, The University of Jordan. Her research interests span medicinal chemistry, nanotechnology, and public health, with significant contributions in optimizing antidiabetic candidates, cancer treatments, and developing advanced analytical techniques. Ghadeer has published extensively and holds several patents.

Profile

Education🎓

From 2001 to 2004, Ghadeer A. Suaifan pursued a PhD in Medicinal Chemistry and Instrumental Analysis at the Department of Pharmacy and Pharmacology, University of Bath, UK. Prior to this, she completed an MPhil in Medicinal Chemistry and Instrumental Analysis at the same institution from 2000 to 2001. Ghadeer began her academic journey with a BSc (Honours) in Pharmacy from the College of Pharmacy, Petra University, Amman, Jordan, which she completed between 1991 and 1996. Her foundational education was acquired at Al-Room Al-Catholic School in Zarka, Jordan, where she earned her General Secondary Education Certificate from 1988 to 1991.

Experience 🏢

Prof. Ghadeer Suaifan is a distinguished Professor of Medicinal Chemistry and Pharmaceutical Instrumental Analysis at the Faculty of Pharmacy, The University of Jordan, where she has been serving since September 2016. In this role, she leads advanced research and teaching, significantly contributing to the academic and research excellence of the institution. Prior to this, she held the position of Associate Professor from September 2012 to September 2016, during which she focused on enhancing the curriculum and advancing research initiatives in medicinal chemistry and pharmaceutical sciences. From 2005 to 2012, Prof. Suaifan worked as an Assistant Professor at the same faculty, delivering undergraduate and postgraduate courses in pharmaceutical sciences and engaging in significant research activities. Additionally, she served as an Assistant Professor at the Faculty of Pharmacy, Philadelphia University, Amman, Jordan, from 2004 to 2005, where she contributed to the development of pharmaceutical education and research. Prof. Suaifan’s extensive experience and dedication have made her a vital asset to the field of pharmaceutical sciences in Jordan.

Research Interests 🔬

Ghadeer’s research encompasses Medicinal Chemistry and Instrumental Analysis, focusing on optimizing new antidiabetic candidates, elucidating molecular structures, and developing advanced prodrug systems for prostate cancer. Her work extends to Nanotechnology, including biological particle detection, miniaturized instrumentation, and medical diagnostics. She also investigates Public Research, evaluating antibiotic use behaviors and the prevalence of Complementary and Alternative Medicine in Jordan.

Special Awards 🏆

Professor Ghadeer Suaifan has been recognized for her outstanding contributions to research and development. She received the prestigious Ibtikar Award from Mewiin, Kuwait, in 2020. Her dedication to scientific research was further acknowledged with the Samia Mango Award from the Hamdi Mango Center for Scientific Research in Amman, Jordan, in 2018. In 2015, she was honored with the Excellent Oral Presenter Award at the International Conference on Pharmaceutical Sciences (ICPS) held in Dubai. Professor Suaifan’s academic achievements were consistently recognized during her time at the Faculty of Pharmacy, Petra University, where she received University Awards for Best Achievement from 1991 to 1996. In addition to her accolades, she has been a Registered Pharmacist with the Jordanian Pharmacists Association in Amman since January 1996, showcasing her longstanding commitment to the pharmaceutical profession and her continuous contributions to the field.

Publications Top Notes 📚

  1. Magnetic beads-based nanozyme for portable colorimetric biosensing of Helicobacter pylori
    • Authors: Suaifan, G.A.R.Y., Shehadeh, M.B., Darwish, R.M., Alaridah, N., Zourob, M.
    • Year: 2024
    • Journal: Biosensors and Bioelectronics: X, Volume 20, Article 100517
  2. Rapid Colorimetric Quantitative Portable Platform for Detection of Brucella melitensis Based on a Fluorescence Resonance Energy Transfer Assay and Nanomagnetic Particles
    • Authors: Alhogail, S., Chinnappan, R., Suaifan, G.A., Jürgen, P., Zourob, M.M.
    • Year: 2024
    • Journal: ACS Omega, Volume 9, Issue 19, Pages 20997–21005
  3. A cross-sectional study on adult lifestyle habits during the COVID-19 pandemic
    • Authors: Suaifan, G.A.R.Y., Abu-Odeh, A.M., Shehadeh, M.B., Jbara, W.A., Nassar, R.I.
    • Year: 2024
    • Journal: PLoS ONE, Volume 19, Issue 5, Article e0299668
  4. Synthesis, urease inhibitory and anticancer evaluation of glucosamine-sulfonylurea conjugates
    • Authors: Suaifan, G.A.R.Y., Shehadeh, M., Tahboub, D., Gaurav, A., Khan, M.
    • Year: 2024
    • Journal: Medicinal Chemistry Research, Volume 33, Issue 4, Pages 663–676
  5. Glucosamine substituted sulfonylureas: IRS-PI3K-PKC-AKT-GLUT4 insulin signalling pathway intriguing agent
    • Authors: Suaifan, G.A.R.Y., Alkhawaja, B., Shehadeh, M.B., Hor Kuan, C., Okechukwu, P.N.
    • Year: 2024
    • Journal: RSC Medicinal Chemistry, Volume 15, Issue 2, Pages 695–703
  6. Development of Rapid Aptamer-Based Screening Assay for the Detection of Covid-19 Variants
    • Authors: Aloraij, Y.M., Suaifan, G.A.R.Y., Shibl, A., Al-Kattan, K., Zourob, M.M.
    • Year: 2023
    • Journal: ACS Omega, Volume 8, Issue 36, Pages 32877–32883
  7. Medicinal plants of Jordan: Scoping review
    • Authors: Abu-Odeh, A., Fino, L., Al-Absi, G., Shehadeh, M., Suaifan, G.
    • Year: 2023
    • Journal: Heliyon, Volume 9, Issue 6, Article e17081
  8. Antibiotic—Lysobacter enzymogenes proteases combination as a novel virulence attenuating therapy
    • Authors: Suaifan, G.A.R.Y., Abdel Rahman, D.M.A., Abu-Odeh, A.M., Shehadeh, M.B., Darwish, R.M.
    • Year: 2023
    • Journal: PLoS ONE, Volume 18, Issue 3, Article e0282705
  9. Knowledge, practice and attitude associated with SARS-CoV-2 Delta Variant among adults in Jordan
    • Authors: Suaifan, G.A.R.Y., Abu-Odeh, A.M., Shehadeh, M.B., Shahwan, M., Jbara, F.A.
    • Year: 2022
    • Journal: PLoS ONE, Volume 17, Issue 12, Article e0278243